SIGNATOPE

SIGNATOPE

SIGNATOPE

SIGNATOPE develops the next generation of protein biomarker assays using a special type of immunoaffinity based mass spectrometry assays.
Founded
2016
Raised
$722.9k
Follow us
Alexa global traffic share